|
UNC119B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.41599999999398E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.481800E-01 |
| Normal-vs-Stage2 |
3.582500E-03 |
| Normal-vs-Stage3 |
8.28419999265861E-10 |
| Normal-vs-Stage4 |
9.31229982015225E-10 |
| Stage1-vs-Stage2 |
2.083800E-02 |
| Stage1-vs-Stage3 |
1.5255000040959E-08 |
| Stage1-vs-Stage4 |
3.19240001100951E-09 |
| Stage2-vs-Stage3 |
7.117900E-02 |
| Stage2-vs-Stage4 |
3.870100E-02 |
| Stage3-vs-Stage4 |
7.512400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.28150000000094E-05 |
| Normal-vs-AfricanAmerican |
1.284170E-02 |
| Normal-vs-Asian |
3.917600E-01 |
| Caucasian-vs-AfricanAmerican |
9.928000E-01 |
| Caucasian-vs-Asian |
6.174000E-01 |
| AfricanAmerican-vs-Asian |
6.254800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.210550E-04 |
| Normal-vs-Female |
1.641110E-04 |
| Male-vs-Female |
7.268400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.419900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.475580E-03 |
| Normal-vs-Age(61-80Yrs) |
4.13529999999662E-05 |
| Normal-vs-Age(81-100Yrs) |
6.834200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.658200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.361000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.564600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.133600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.488800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.516800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.127600E-01 |
| Normal-vs-Grade 2 |
2.175000E-01 |
| Normal-vs-Grade 3 |
2.75790000003884E-06 |
| Normal-vs-Grade 4 |
1.63247193540883E-12 |
| Grade 1-vs-Grade 2 |
5.433000E-01 |
| Grade 1-vs-Grade 3 |
5.227800E-02 |
| Grade 1-vs-Grade 4 |
3.89960000002354E-06 |
| Grade 2-vs-Grade 3 |
3.577800E-04 |
| Grade 2-vs-Grade 4 |
2.74225087082414E-13 |
| Grade 3-vs-Grade 4 |
1.58160000000018E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.252800E-01 |
| Normal-vs-ccB subtype |
2.07149963848963E-10 |
| ccA subtype-vs-ccB subtype |
2.4287016842095E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.21550000004223E-06 |
| Normal-vs-N1 |
9.762300E-03 |
| N0-vs-N1 |
3.000200E-01 |
|
|
